Patient outcomes and longevity on HVAD support

Number of HVAD & MVAD Patients on Support Worldwide

1,734 HVAD & MVAD Patients on Support Worldwide as of Q4FY24.

Source: HVAD site reported data, Q4FY24. Not independently confirmed or validated by Medtronic.

Number of Years on Support for Ongoing HVAD Supported Patients*

MCS HVAD Clinician Tool Survival Original Device

*Data as reported by US sites through April 12, 2024 (n = 760).

 

Kaplan-Meier Estimate for Overall Survival1 in a Contemporary HVAD System Cohort2 per the Quarterly STS Intermacs Report3

Patient hvad implant graph

Reproduced with the permission of The Society of Thoracic Surgeons.
Copyright © 2024 The Society of Thoracic Surgeons.

  1. Subjects were censored at the time of any non-death related explant.
  2. Contemporary cohort was stratified by year-of-implant following FDA approval of the HVAD System for Destination Therapy (October 2017) through cessation of the sale and distribution of the device (June 2021): October-December 2017, 2018, 2019, 2020, January–June 2021.
  3. STS Intermacs Report with follow-up through 31 December 2023.

STS – Society of Thoracic Surgeons; Intermacs – Interagency Registry of Mechanically Assisted Circulatory Support; FDA – Food and Drug Administration.